Navigation Links
Cephalon Presents Positive Results for Fentora in Breakthrough Pain,,,Associated with Neuropathic Conditions

mation on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs; development of potential pharmaceutical products, including any future indications for FENTORA; interpretation of clinical results, including the results of the clinical trials of FENTORA in patients with neuropathic pain; prospects for regulatory approval; market prospects for its product; sales and earnings guidance; and other statements regarding matters that are not historical facts. You may identify some of these forward- looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.

'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference

Post Your Comments:
(Date:11/7/2009)...a., Nov. 7 Patients reported C1-es...ive therapy in treating acute swelling attacks at ...tic disorder, according to data presented today at...; Immunology (ACAAI) Annual Meeting. The results c...ted in parallel with the ongoing, prospective, ope...
(Date:11/6/2009)...ov. 6 Oxygen Biotherapeu...ced that a previously approved reverse split of it...ading on Monday, Nov. 9, 2009 on a 1-for-15 split-...s will trade under the new symbol OXBT. The stock ...en the split becomes effective. ,, "This revers...
(Date:11/6/2009)...s., Nov. 6 DUSA Pharmace...logy company that is developing and marketing Levu...roducts focused on patients with common skin condi...ef Executive Officer, will present a corporate ove...2009 on Tuesday, November 10, 2009 at 10:00 a.m. E...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Spain 26apos 3Bs Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season 14297 1Spain 26apos 3Bs Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season 14297 2Spain 26apos 3Bs Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season 14297 3Prodigy Diabetes Care LLC Expands Global Reach to European Diabetes Patients 58540 1Prodigy Diabetes Care LLC Expands Global Reach to European Diabetes Patients 58540 2Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 58538 1Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 58538 2Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 58538 3
... DIEGO, March 20 Valor Medical, an emerging medic...y that the first human,implant of Neucrylate AN fo... Dr. Sean Pakbaz at the University of Tehran. The ...tocol that had been approved by the University,s,I... the patient,s aneurysm was a type and location,th...
...ision makes convenient self-testing a financial re...ion patients, INDIANAPOLIS, March 19 Medicare Pa...uipment and supplies for all long-term,warfarin us...h a portable,handheld meter. The change opens the ...complications for a broader spectrum of anticoagul...
Other Medicine Technology:Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home 2Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home 3Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home 4
(Date:11/8/2009)...ift Passage of H.R. 3961 to Secure the Stability o...wswire/ -- Statement Attributable to: J. James Roh.... ,, (Logo: http://www.newscom.com/cgi-bin/pr...assage of the House health reform bill, which will...hysicians and calls for swift passage of H.R. 3961...
(Date:11/8/2009)... House Passage of Health Care Reform Bill ,, ...prove coverage for all Americans ,, BALTIMORE,...ght the United States House of Representatives pas...ould strengthen Medicare for seniors and end discr...ons of Americans out of affordable health coverage...
(Date:11/7/2009)... 7, The American Medica...n Rush Award for Citizenship and Community Service...Chicago, IL. The award recognizes physicians who h...of duty to make an outstanding public service cont...ved the award today during the opening session of ...
(Date:11/7/2009)... 7 Members of the AMA a...rgency resolution rescinding the AMA,s support of ... they are responsible to their PATIENTS, not the l...or of Policy for the Association of American Physi...ition of other medical groups. ,, "If the AMA ...
(Date:11/7/2009)...ov. 7 Speaker Nancy Pel...ty this afternoon following a Democratic Whip meet.... Below are the Speaker,s opening remarks: ,,...eat occasion for us to receive the President of th... history with our vote and making progress for the...
Breaking Medicine News(10 mins):Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2
...dreaded disease, meant death two decades ago. It s... and complete cure is possible if diagnosed early....its occurrence. A new study reports that some type...rding to this new study published in Annals of the...
...ed a cost-effective solar energy bathing scheme fo...cs //show that 200 million out of China's 800 mill... energy experts have devised a bathing scheme aime...quarter or every six months, leading to a high num...
...style of working parents is having a toll on the h...Delhi Diabetes Research Centre.// Fast and j...o are allowed to spend their pocket money in these... The excess saturated fat in fast foods is result...
...RSA has baffled experts and in a new move to conta...g that forbids Doctors//, and staff of hospitals, ...r any ‘unnecessary’ clothing and accessories- ties...with an effort to bring down the rate of MRSA infe...
...dents in Madhya Pradesh took part in an AIDS aware... the fatal virus.// The students tied 'surak...nday to symbolise their awareness of HIV and their...t of a 'Unite for Children, Unite Against AIDS' dr...
...ogies, Inc., a developer of next-generation medica...recently presented results of animal studies that ...upport system to significantly improve the treatme... Researchers found that key biomarkers of heart f...
Other Medicine News:Health News:Child Obesity and Diabetes - A Major Problem in India, 2Health News:Positive Animal Study on MYO-VAD, Promise for Treatment of Heart Failure 2
Zebra 140xiIII Barcode Printer
...use technology that improves patient outcomes. Rig...o-use BD.id Patient Identification System for Spec..., the patient, the specimen container, and the ord...able labels only for specimens actually collected,...
...cation and laboratory specimen labeling system use...ist or nurse, the identity of the patient and the ...e, a bar coded sample ID label is printed right at...minates the interface problems inherent with other...
...ns, a Cerner point-of-care solution, is a bar-code...llection. The solution enhances the safety and acc...ying bar-code scanning technology, wireless networ...prevent potential patient identification and speci...
Medicine Products: